![BiomX Inc. logo](/logos/PHGE.webp)
BiomX Inc.
AMEX:PHGE
Overview | Financials
Company Name | BiomX Inc. |
Symbol | PHGE |
Currency | USD |
Price | 0.41 |
Market Cap | 18,851,677 |
Dividend Yield | 0% |
52-week-range | 0.132 - 0.69 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonathan Eitan Solomon MBA |
Website | https://www.biomx.com |
An error occurred while fetching data.
About BiomX Inc.
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD